Home/Filings/4/0000899243-21-005461
4//SEC Filing

Seymour Albert 4

Accession 0000899243-21-005461

CIK 0001661998other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:25 PM ET

Size

7.9 KB

Accession

0000899243-21-005461

Insider Transaction Report

Form 4
Period: 2021-02-05
Seymour Albert
Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2021-02-05+13,00013,000 total
    Common Stock (13,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-02-05+78,00078,000 total
    Exercise: $13.78Exp: 2031-02-05Common Stock (78,000 underlying)
Footnotes (3)
  • [F1]The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

Issuer

Homology Medicines, Inc.

CIK 0001661998

Entity typeother

Related Parties

1
  • filerCIK 0001735324

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:25 PM ET
Size
7.9 KB